AVV February 2005 Support of the European Union to Research on Rare Diseases Dr Alain Vanvossel European Commission Research Directorate General Health.

Slides:



Advertisements
Similar presentations
Leonardo Piccinetti EFB
Advertisements

European Economic and Social Committee Consultative Committee on Industrial Change "CCMI" P r e s e n t a t i o n of J á n o s T Ó T H Member of the EESC.
The future of EU research Rudolf Meijer, European Commission Prague, 26 May 2004 Annex X.
Illustrated Story on funding research Europides has got the instruments!
Slide 1 Research in support to Human Biomonitoring E&H, Consultative Forum Meeting 19 October 2005 Luxembourg P. Valette DG Research, Directorate Environment.
1 Community Support to Forest related Research European forest research – outlook for the future Brussels, 12 November 2004 Christian PATERMANN Director.
Forestry value chain meeting
EC -DG Research Dir. D : Human Factor, Mobility and Marie Curie Actions The provided information might still be revised TRAINING THE TRAINERS Initial training.
European Commission Research 1 The 6th FRAMEWORK PROGRAMME FOR RESEARCH AND TECHNOLOGICAL DEVELOPMENT Richard ESCRITT Director Co-ordination of Community.
DG ResearchEuropean Commission 1 DG RTD/E.2/JL - 8/16/2014 Scientific Support to Policies Dr. Hans-Jörg Lutzeyer European Commission Research Directorate-General.
Stefano Fontana European Commission DG RTD Research for the benefit of SMEs SMEs in the.
November 2004 The Research Infrastructures in FP7 DG RTD – Directorate ‘Structuring ERA’
NMP-NCP meeting - Brussels, 27 Jan 2005 Towards FP 7: Preliminary principles and orientations… Nicholas Hartley European Commission DG Research DG Research.
A European Strategy for Marine and Maritime Research
Grant Information Search Dr. E. K. Ingbian Associate professor ( Department of Food Science and Technology ) Directorate of Research and Development University.
9th Grove Fuel Cell Symposium, 6th October 2005 Sustainable Energy Systems Slide n° 1 7 th FRAMEWORK PROGRAMME BUILDING THE EUROPE OF KNOWLEDGE European.
Research and Innovation Research and Innovation Enabling & Industrial Technologies in Horizon 2020 Enabling & Industrial Technologies in Horizon 2020 Research.
EU support for Health Research: from FP6 to FP7
1 E-Frame “European Framework for Measuring Progress” - The contribution to Europe 2020 and European Research Area policies and to European Statistical.
1 Conference, How does research integration work? 17 June 2008 The issue of ‘research integration’ and the role of IPs and NoE in the social sciences and.
European research under FP7 for Small and Medium Enterprises Bari, 16 September 2006 Gianluca Coluccio European Commission ▪ DG Research Unit M4: Research.
EU RTD + FP Cancer Treatment: A priority for patients in Europe 7 th European Health Forum Bad Gastein 7 October, 2004 Cornelius Schmaltz MD European.
1 DG Research – Science & Society Women and Science Johannes Klumpers DG Research - European Commission
22 Feb 2007EU-Russia Co-operation1 Dr. Stephan Pascall Advisor to the Director Directorate G: Components and Systems DG Information Society and Media European.
1 7th Framework Programme Specific Programme “Ideas” European Commission Directorate B November 2005.
Companies and the Sixth Framework Programme. Agenda Overview of the 6 th Framework Programme (FP6) Why participate ? Industry participation in FP6 What’s.
Research and Innovation Research and Innovation Research and Innovation Research and Innovation Research Infrastructures and Horizon 2020 The EU Framework.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.
Sixth Framework Programme INTRODUCTION . Contents Contents of FP6 Instruments in FP6 Financing Budgets Timetable Highlights.
FP 6- Thematic Priority 4 Aeronautics & Space Joseph Prieur - Aeronautics DG Research- Space &Transport.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
EURATOM RESEARCH AND TRAINING ON NUCLEAR ENERGY 1.
SMEs "Perspectives of SME participation in FP 7“ SEE Innovation - workshop Sofia, 9th February 2006 Henrik Dam European Commission DG Research, Research.
Polish Presidency and FP7 undertakings for research&innovation – facing Horizon 2020 Anna Pytko National Contact Point in Poland Institut of Fundamental.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 The Sixth Framework Programme and Policy Support Research – “Priority 8” Parallel.
FP6 Project Organisation. Participating in FP6 How Projects Are Organised FP6 research projects are almost always collaborative 1 and implemented using.
Work Programme for the specific programme for research, technological development and demonstration "Integrating and strengthening the European Research.
Space in the 7 th Research Framework Programme Università Politecnica delle Marche – 20 Maggio 2005 Mauro FACCHINI European Commission DG Enterprises and.
RTD-B.4 - Regions of Knowledge and Research Potential Regional Dimension of the 7th Framework Programme Regions of Knowledge Objectives and Activities.
1 EU-funded health research activities against TB: FP6 actions and perspectives toward FP7 DG Research - European Commission 22 MARCH 2007.
Practical aspects Dr. Ir Matthijs Soede Senter/EG-Liaison “Practical Aspects of Preparation FP6 projects Poznan - 21 November 2002 Dr. Ir.
Фондация ГИС Трансфер Център г. Sofia Лектор: Kostadin Kostadiov Проект: EURESP+, ENT/CIP/10/D/
Building the Europe of Knowledge Proposals for the 7 th Research Framework Programme
Peter Härtwich Directorate Coordination of Community Actions DG Research, European Commission The Commission proposal for the 7th Framework Programme
S&T cooperation Mediterranean and EU countries Spanish proposal Casablanca, 17th November 2009 Dr Angeles Rodríguez-Peña Deputy European Programmes Ministry.
FP7 /1 EUROPEAN COMMISSION - Research DG – September 2006 Building a Europe of Knowledge Towards the Seventh Framework Programme
The Seventh Framework Programme for Research and Technological Development (FP7) supporting innovation Epp Tohver-Bulavs 07. November 2007, Tallinn.
EURORDIS Eurordis Position on Research Priorities for Rare Diseases.
FP7 – Nov Towards the EU Seventh Framework Programme (FP7) European Commission Research DG.
Poznan 19 April Kwietnia 2005 Poznan FP6 The Next Calls for 2005 Technology Platforms FP7.
E u r o p e a n C o m m i s s i o nCommunity Research Global Change and Ecosystems EU environmental research : Part B Policy objectives  Lisbon strategy.
China July 2004 The European Union Programmes for EU-China Cooperation in ICT.
Alun JONES EU Network Manager European Agency for Safety and Health at Work 6 th Framework Programme on Research.
FP7 /1 EUROPEAN COMMISSION - DG Research Building a Europe of Knowledge Towards the SeventhFrameworkProgramme
1 Priority 3 NMP: generalities Renzo TOMELLINI Head of Unit “Nanosciences and Nanotechnologies” Directorate “Industrial Technologies” Research Directorate-general.
EHFG 7 October 2005 – Patient Safety & Research UK Presidency Workshop on Patient Safety, EHFG, Bad Hofgastein,7 September 2005 Kevin McCarthy, European.
Practical Aspects of Preparation FP 6 projects Senter/EG-Liaison Nationaal Contact Punt voor het 6de Kaderprogramma Sandra de Wild 11 december 2002.
The 7th Framework Programme for Research: Strategy of international cooperation activities Robert Burmanjer Head of Unit, “International Scientific Cooperation.
6th Framework Programme Implementation of Priority 3 Dir G - DG Research Warszawa, 20go stycznia 2003.
Research and Innovation Research and Innovation Promoting health research and innovation in Horizon 2020 Research and Innovation Research and Innovation.
Richard Escritt, Director – Coordination of Community Actions DG Research, European Commission “The development of the ERA: Experiences from FP6 and reflections.
2. The funding schemes ICT Proposer’s Day Köln, 1 February 2007 The ICT Theme in FP7 How to participate to ICT in FP 7.
The Seventh Framework Programme
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Regional Research-driven clusters as a tool for strenghthening regional economic development: the FP7 Regions of Knowledge Programme and its synergies.
Priority 3 NMP: generalities
European Union – Russia Brokerage Event
The challenge of European Research
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Experience of the implementation of FP6; preparations towards FP7
Presentation transcript:

AVV February 2005 Support of the European Union to Research on Rare Diseases Dr Alain Vanvossel European Commission Research Directorate General Health Directorate - Major Diseases Unit

AVV February 2005 Directorate General for Research = European public research funding body complementation of private sector- funded research European added value Framework Programme RARE DISEASES Rare Diseases: is research needed?

AVV February 2005 General objectives of FP - Health: improve the prevention and management of important causes of mortality and ill health in Europe, pool Europe’s research resources for tackling (rare) diseases. Specific objectives of FP: Topics mentioned in the work programmes of the calls for proposals Rare Diseases: is research needed?

AVV February 2005 Previous programmes: Promote cooperation, collaboration and knowledge building EU historical support to RD research FP5: Total 45 RD projects, € 62 million R&D: Friedreich's Ataxia; Peroxisomal diseases; Myopathies; Congenital disorders of glycosylation; Juvenile systemic lupus erythematosus; Cystic fibrosis INFRA: European network of DNA, cell and tissue banks on rare diseases Biotech: Gene therapy for inherited diseases; Genechip technology for detection of molecularly heterogeneous genetic diseases Such asSuch as

AVV February 2005 Make a reality of the “European Research Area”, with a view to stepping up innovation in Europe, in conjunction with all the efforts made to this end at regional, national and European level. RD research in FP6 FP6: Develop scientific and technical excellence

AVV February 2005 RD research in FP6

AVV February 2005 How will this be achieved? Necessity to reach a critical mass, management simplification and integration of the research capacities Introduction of new instruments: Integrated Projects (IP) and Networks of Excellence (NoE) To complement STREP/CA/SSA Translate genome data into practical applications to improve human health Objectives of Thematic Priority 1 (overall budget in FP6 : € 2255 Million) RD research in FP6

AVV February 2005 PRIORITY 1: Life Sciences, Genomics and Biotechnology for Health Three calls for proposals already published 26 RD relevant projects selected for funding in the 2 first calls, total budget € 93 million Expected global budget for RD: up to € 150 million RD research in FP6

AVV February 2005 Prader-Willi syndrome (STREP) Rare autoimmune disorders (STREP) Rare genetic skin disorders (CA) Disorders of inborn errors of metabolism (CA) RD of nuclear organisation (STREP) Pharmacogenomics - orphan medicinal products (STREP) Cystic fibrosis (CA) Methodological challenges of early clinical trials in RD (CA or SSA) RD of mitochondria (IP) RD of plasma membrane transporters for amino-acids (STREP) Network for early clinical trials in Wilson disease (CA) Coordination of RD research (SSA) Rare hereditary neurological disorders: ataxias (IP) Rare monogenic neurological disorders (STREP) 1 st Call 2 nd Call 3 rd Call “Rare Diseases” - calls overview

AVV February 2005 e.g. 3rd call: Quality and safety standards for clinical gene transfer - NoE. Workshop on ethical issues raised by new diagnostic methods – SSA. Rare diseases can serve as models for other diseases! ! Rare Diseases  necessary keyword to identify relevant topics in the work programme : RD research in FP6

AVV February 2005 DNA damage and repair mechanisms in health and disease (IP) Functional genomics: study of peroxisomes in health and disease (IP) Low abundance proteomics: cystic fibrosis model (STREP) Rare Diseases (FG + Biotech) Genetic testing in Europe (NoE) Molecular diagnostics in mitochondrial diseases (STREP) Retroviral transgenesis in gene therapy of inherited diseases (IP) Improving precision of nucleic acid-based therapy of cystic fibrosis (STREP) Gene transfer for curative therapy of human skin disease (STREP)

AVV February th call for proposals Emphasis on SMEs! Indicative topics? (not published yet; foreseen June 2005) protein folding rare diseases models bone/cartilage diseases neuromuscular diseases

AVV February 2005 EURO-POLICY-PID (STREP): Policy-oriented and harmonising research activities in primary immunodeficiency diseases (PIDs) Underpin the formulation and implementation of Community policies One action line devoted to Public Health issues, including RD Objectives of Priority 8 RD research in FP6 Encourage and support initiatives undertaken by several countries, to develop synergy between their existing activities, as well as to define and implement joint activities, in areas such as health, including the RD area. Objectives of Coordination of Activities E-Rare (SSA): ERA-Net for research programmes on RD

AVV February 2005 Communication: “Science and technology, the key to Europe’s future – Guidelines for future European Union policy to support research” Open consultation on the future of European research policy Preparation of the proposal for the 7th FRAMEWORK PROGRAMME (FP7) Towards FP7

AVV February Creating European centres of excellence through collaboration between laboratories 2.Stimulating the creativity of basic research through competition between teams at European level 3.Launching European technological initiatives 4.Improving the coordination of national research programmes 5.Making Europe more attractive to the best researchers 6.Developing research infrastructures of European interest Six major objectives: Towards FP7

AVV February 2005 OTHER: Enhance european scientific presence in international setting Stimulate research for and by SME Encourage technology innovation Towards FP7

AVV February 2005 Research Themes for FP7? Open consultation on thematic domains for future European support under FP7 Domains where support at European level is most needed will have the greatest impact based on: European added value Contribution to EU policy objectives European research potential Towards FP7

AVV February 2005 Towards FP7 (Decision on Financial Perspectives) Commission proposal for FP: towards April 2005 Commission proposals for Specific Programmes: towards September 2005 Adoption of FP by European Council and European Parliament: foreseen June 2006 Adoption of Specific Programmes by the European Council: foreseen September 2006 Publication of first calls for proposals: November 2006 Indicative roadmap for FP7

AVV February 2005 Towards FP7 Reflexion workshop April 2005 (DG RTD) Received position papers (e.g. EURORDIS) Conferences: ICORD, Lux. RD conference June 2005 Your free input! Input

AVV February 2005 Cordis website for Priority 1: